Live News REGULATION FLASH M impact Nov 17, 2026, 06:24 PM UTC US FDA Approves GSK’s Second Lung Cancer Drug From Nuvalent Deal The FDA approved GSK’s second lung cancer drug from its deal with Nuvalent. PFE SquawkNews Desk